Opportunities for the Life Science Industry in Australia post-COVID
Regular PharmaBoardroom contributor Brendan Shaw outlines how his home country of Australia has so far successfully managed to avoid the worst of the COVID-19 pandemic, providing opportunities for the life sciences industry to invest in new facilities, research and development in a post-pandemic world. Australia, the island continent A combination of early strict border…
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed